AEON Biopharma, Inc. cotiza a 0.23 USD y tiene una capitalización bursátil de $11M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chr…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.25 | $-3.72 | $-0.39 | $-0.60 |
| Estimado | $-0.44 | $-0.20 | $-0.43 | $-0.35 |
| Sorpresa | +43.2% | -1760.0% | +9.3% | -71.4% |
| Métrica | AEON | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -705.4% | -32.0% | -673.4% |
| Current Ratio | 0.49 | 2.84 | -2.35 |
| Debt / Equity | — | 0.28 | — |